Asymchem is a global contract development and manufacturing organisation (CDMO) with over 25 years of experience, offering integrated solutions across the pharmaceutical value chain. Headquartered in Morrisville, United States, and backed by major R&D and manufacturing operations in China, the U.S., and the U.K., the firm employs around 9,000 professionals. It is publicly listed under stock codes 002821.SZ and 6821.HK

The company is committed to delivering cGMP-compliant, cost-effective services across small molecules, chemical macromolecules, biologics, and synthetic biology. Asymchem distinguishes itself through a robust culture of green chemistry, investment in innovation, and a single-source model that covers the entire drug development lifecycle—from route scouting and process development to scale-up and manufacturing.

Its Chinese facilities operate under stringent regulatory scrutiny—approved by the US FDA and Australian TGA—and the company also integrates Western quality practices throughout its domain

Key Products and Services

Small-molecule APIs and Peptides: Services ranging from process development and optimisation to commercial API manufacturing.

Chemical Macromolecules and Biologics: Development and manufacturing services for more complex molecules

Synthetic Biology Platforms: Including continuous enzymatic catalysis, recombinant expression, high-throughput screening, and oligopeptide/polypeptide biosynthesis

Continuous Flow Chemistry Technologies: Capabilities such as flow reactions, biocatalysis, asymmetric synthesis, catalytic hydrogenation, cryogenic processing, and more

Formulation and Drug Product Development: Pre-formulation, formulation development, analytical services, stability studies and final dosage forms like granulation, encapsulation, tablet coating, etc

Green Chemistry Innovation: Emphasis on environmentally sustainable methods, reduced waste, and efficient synthesis across R&D and manufacturing

End-to-End Solutions: A single-source integration of analytics, compliance, supply-chain assurance, and IP protection across the entire development process

Asymchem stands as a comprehensive CDMO partner for pharmaceutical and biotech clients, offering a broad spectrum of services—from small-molecule API development and synthetic biology platforms to advanced flow chemistry and formulation services—underpinned by a commitment to green innovation and regulatory excellence. With a global footprint spanning China, the U.S., and Europe, and a workforce of approximately 9,000, Asymchem is positioned to support drug development through scientific rigor, operational integration, and sustainable practices.